This year lab members Antje Schaefer and Andrew Waters presented at the FASEB: Regulation and Function of Small GTPases Conference in Olean, New York. Antje's presentation, pictured below, was on "The gain-of-function mutation Y42C in RHOA promotes FAK activation and dependency in diffuse gastric cancer."
Lab Members Learn (and Laugh) at Annual Retreat
This summer, the Der, Cox, Campbell, and Counter labs visited Emerald Isle, NC. Together they spent three days giving talks, getting to know one another, and discussing upcoming projects.
Der Lab Berlin
Der Lab Berlin has been officially established at Charité, Universitätsmedizin Berlin in Germany. Charité was established in 1710 by King Frederick I of Prussia, in preparation for the bubonic plague. It was later used as a charity hospital for the poor and eventually integrated as a teaching hospital for Universitätsmedizin Berlin in 1828. It has … Continue reading Der Lab Berlin
Der Lab Par’bakes’ in a Cox Lab Tradition
The front room was crowded with lab members. Some hunched over a bench and others gingerly dodged with full trays between rooms. One lab member, gripping tweezers with the grace of a Venetian painter, dedicatedly arranged sprinkles on a rainbow-glazed sugar cookie. Take the energy of a family holiday dinner and the methodological focus of … Continue reading Der Lab Par’bakes’ in a Cox Lab Tradition
Tumor Targets Panel– Ruesch Center Annual Symposium 2018
https://www.youtube.com/watch?v=Nc-uE0Dzff0&feature=youtu.be Dr. John Marshall hosted a panel at the 2018 Ruesch Center Annual Symposium focused on tumor targets. Panel guests were Dr. Eric Collisson, Dr. Channing Der, and Dr. Michael Korn. Dr. Eric Collisson discusses the emergence in oncology of a new class of drugs called PARP inhibitors. These have been more commonly used in … Continue reading Tumor Targets Panel– Ruesch Center Annual Symposium 2018
UNC Lineberger Writes: Researchers identify resistance mechanism to possible pancreatic cancer treatment
In the journal Cancer Cell, UNC Lineberger's Channing Der, PhD, and colleagues described how pancreatic cancer may develop resistance to ERK inhibitors in pancreatic cancer. November 16, 2018 Despite decades of research, treatments that can target a common mutation in the most frequently diagnosed type of pancreatic cancer have remained elusive. Now, University of North … Continue reading UNC Lineberger Writes: Researchers identify resistance mechanism to possible pancreatic cancer treatment
UNC Lineberger Writes: Der receives NCI Outstanding Investigator Award
The National Cancer Institute’s Outstanding Investigator Award supports accomplished leaders in cancer research. November 13, 2018 UNC Lineberger’s Channing Der, PhD, has been awarded the National Cancer Institute’s Outstanding Investigator Award, which supports accomplished leaders in cancer research who are working on science with breakthrough potential. The award provides up to $600,000 in direct costs per … Continue reading UNC Lineberger Writes: Der receives NCI Outstanding Investigator Award
Channing Der Granted 2018 NCI Outstanding Investigator Award
The NCI Outstanding Investigator Award (OIA) supports investigators with outstanding records of productivity in cancer research by providing extended funding stability and encouraging investigators to continue or embark on projects of unusual potential in cancer research. The research funded will focus on exploiting novel protein kinases that regulate MYC protein stability to cause MYC loss, … Continue reading Channing Der Granted 2018 NCI Outstanding Investigator Award
2018 Lineberger Graduate Fellow Award Winners Announced
On Tuesday, October 16th Pharmacology Chair Dr. Henrik G. Dohlman announced two of the 2018 Lineberger Award: Irem Dagliyan and Devon Blake. Irem and Devon are both members of the Der Lab at the UNC Lineberger Comprehensive Cancer Research Center. The annual award recognizes outstanding graduate students in the research programs at the Lineberger. Irem … Continue reading 2018 Lineberger Graduate Fellow Award Winners Announced
Slomo and Cindy Silvian Foundation Support Der Lab
In November of 2017, the Der Lab was granted $30,000 from the Slomo and Cindy Silvian Foundation, Inc. to aid graduate student stipend support. This award will support Irem Dagliyan, who is completing her graduate research in the Department of Pharmacology. Irem’s research is focused on the RAF protein kinases, key effectors of KRAS-driven pancreatic cancer … Continue reading Slomo and Cindy Silvian Foundation Support Der Lab
Der Lab 